Title : Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC.

Pub. Date : 2013 Oct

PMID : 23740383






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 While the beta blocker carvedilol (1 muM) normalized the level of p53 and Bcl-2 and the calcium channel blocker (CCB) bepridil (0.5 muM) normalized that of Bcl-2, both the CCB azelnidipine (1 muM) and the angiotensin receptor blocker (ARB) olmesartan (10 muM) normalized those of p53, Bax, cytochrome c, and Bcl-XL. Bepridil latexin Homo sapiens
2 While the beta blocker carvedilol (1 muM) normalized the level of p53 and Bcl-2 and the calcium channel blocker (CCB) bepridil (0.5 muM) normalized that of Bcl-2, both the CCB azelnidipine (1 muM) and the angiotensin receptor blocker (ARB) olmesartan (10 muM) normalized those of p53, Bax, cytochrome c, and Bcl-XL. Bepridil latexin Homo sapiens
3 While the beta blocker carvedilol (1 muM) normalized the level of p53 and Bcl-2 and the calcium channel blocker (CCB) bepridil (0.5 muM) normalized that of Bcl-2, both the CCB azelnidipine (1 muM) and the angiotensin receptor blocker (ARB) olmesartan (10 muM) normalized those of p53, Bax, cytochrome c, and Bcl-XL. Bepridil latexin Homo sapiens